UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000016772
Receipt number R000019465
Scientific Title The study of Metabolic Improvement by Nutritional Intervention controlling Endogenous GIP: A randomized controlled trial of two different diets
Date of disclosure of the study information 2015/03/11
Last modified on 2018/01/30 10:49:51

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The study of Metabolic Improvement by Nutritional Intervention controlling Endogenous GIP: A randomized controlled trial of two different diets

Acronym

The study of Metabolic Improvement by Nutritional Intervention controlling Endogenous GIP (Mini Egg study): A randomized controlled trial of two different diets

Scientific Title

The study of Metabolic Improvement by Nutritional Intervention controlling Endogenous GIP: A randomized controlled trial of two different diets

Scientific Title:Acronym

The study of Metabolic Improvement by Nutritional Intervention controlling Endogenous GIP (Mini Egg study): A randomized controlled trial of two different diets

Region

Japan


Condition

Condition

Overweight and Obesity

Classification by specialty

Endocrinology and Metabolism Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The aim of this study is to examine the comparative effects of unbalanced diet and well-balanced diet on visceral fat loss in overweight and obese subjects

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Change in visceral fat area

Key secondary outcomes

Change and percent change in body weight, waist circumference, hip circumference, body fat, glucose-related markers, lipid markers, oxidative stress markers, blood biochemical parameters


Base

Study type

Interventional


Study design

Basic design

Cross-over

Randomization

Randomized

Randomization unit

Individual

Blinding

Single blind -participants are blinded

Control

Active

Stratification

YES

Dynamic allocation

NO

Institution consideration

Institution is considered as a block.

Blocking

YES

Concealment

Central registration


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Food

Interventions/Control_1

An unbalanced diet (2096kcal; Protein=13.7%, Fat=37.5%, Carbohydrate/dietary fiber ratio >=15, omega-3/fat ratio <=0.04), for 2 weeks -> Washout, for 4 weeks -> A well-balanced diet (2096kcal; Protein=22.3%, Fat=20.8%, Carbohydrate/dietary fiber ratio <=15, omega-3/fat ratio >=0.04), for 2 weeks

Interventions/Control_2

A well-balanced diet (2096kcal; Protein=22.3%, Fat=20.8%, Carbohydrate/dietary fiber ratio <=15, omega-3/fat ratio >= 0.04), for 2 weeks -> Washout, for 4 weeks -> An unbalanced diet (2096kcal; Protein=13.7%, Fat=37.5%, Carbohydrate/dietary fiber ratio >=15, omega-3/fat ratio <= 0.04), for 2 weeks

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

59 years-old >=

Gender

Male

Key inclusion criteria

1) Japanese male, Age >=20 and <=59 years
2) Body mass index >=23 kg/m2
3) Informed consent provided
4) Able to receive and cook experimental diet
5) Able to follow the instructions of the study team
6) Participated in a meal tolerance test

Key exclusion criteria

1) Plasma glucose value >=126 mg/dL (7.0 mmol/L), LDL-cholesterol value >=180 mg/dL (4.65 mmol/L), Triglyceride value >=300 mg/dL (3.4 mmol/L), Systolic blood pressure >=160 mmHg
2) Weight change during past 1 year >=3 kg
3) Severe liver dysfunction or renal dysfunction
4) Shift worker and night-shift worker
5) Food allergy and suspected food allergy (Self-reported)
6) An unbalanced diet (not able to eat fish and meat)
7) Poor physical health such as rapid weight loss during past 2 months
8) Plan to lose weight through vigorous exercise and resistance training
9) Subjects judged by the investigator/project leader to be ineligible for other reasons

Target sample size

35


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Naoki Sakane

Organization

Clinical Research Institute, National Hospital Organization Kyoto Medical Center

Division name

Division of Preventive Medicine

Zip code


Address

1-1 Mukaihata-cho, Fukakusa, Fushimi-ku, Kyoto

TEL

+81-75-641-9161

Email

nsakane@kyotolan.hosp.go.jp


Public contact

Name of contact person

1st name
Middle name
Last name Naoki Sakane

Organization

Clinical Research Institute, National Hospital Organization Kyoto Medical Center

Division name

Division of Preventive Medicine

Zip code


Address

1-1 Mukaihata-cho, Fukakusa, Fushimi-ku, Kyoto

TEL

+81-75-641-9161

Homepage URL


Email

nsakane@kyotolan.hosp.go.jp


Sponsor or person

Institute

National Hospital Organization Kyoto Medical Center

Institute

Department

Personal name



Funding Source

Organization

Biological Science Research, Kao Corporation

Organization

Division

Category of Funding Organization

Profit organization

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2015 Year 03 Month 11 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2014 Year 12 Month 24 Day

Date of IRB


Anticipated trial start date

2015 Year 03 Month 16 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2015 Year 03 Month 11 Day

Last modified on

2018 Year 01 Month 30 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000019465